Monte Rosa Therapeutics, Inc.盘中异动股价大跌5.29%

市场透视2025-05-22

北京时间2025年05月22日01时21分，Monte Rosa Therapeutics, Inc.（GLUE.us）股票出现异动，股价快速下挫5.29%。截至发稿，该股报3.94美元/股，成交量25.6369万股，换手率0.42%，振幅4.09%。最近的财报数据显示，该股实现营业收入84.93百万美元，净利润46.89百万美元，每股收益0.57美元，毛利82.88百万美元，市盈率33.08倍。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2537958136?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-22 01:21","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2537958136","market":"us","top_or_hot":-1,"title":"Monte Rosa Therapeutics, Inc.盘中异动 股价大跌5.29%","media":"市场透视","content":"<div>\n<p>北京时间2025年05月22日01时21分，Monte Rosa Therapeutics, Inc.（GLUE.us）股票出现异动，股价快速下挫5.29%。截至发稿，该股报3.94美元/股，成交量25.6369万股，换手率0.42%，振幅4.09%。最近的财报数据显示，该股实现营业收入84.93百万美元，净利润46.89百万美元，每股收益0.57美元，毛利82.88百万美元，市盈率33.08倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052201211694fe2de5&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Monte Rosa Therapeutics, Inc.盘中异动 股价大跌5.29%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMonte Rosa Therapeutics, Inc.盘中异动 股价大跌5.29%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-22 01:21 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052201211694fe2de5&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年05月22日01时21分，Monte Rosa Therapeutics, Inc.（GLUE.us）股票出现异动，股价快速下挫5.29%。截至发稿，该股报3.94美元/股，成交量25.6369万股，换手率0.42%，振幅4.09%。最近的财报数据显示，该股实现营业收入84.93百万美元，净利润46.89百万美元，每股收益0.57美元，毛利82.88百万美元，市盈率33.08倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052201211694fe2de5&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052201211694fe2de5&s=b","article_id":"2537958136","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052201211694fe2de5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2537958136","pubTimestamp":1747848076,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年05月22日01时21分，Monte Rosa Therapeutics, Inc.股票出现异动，股价快速下挫5.29%。Monte Rosa Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.06%。Monte Rosa Therapeutics, Inc.公司简介：Monte Rosa Therapeutics Inc 是一家生物技术公司，专门开发分子胶降解剂，这是一类利用人体天然蛋白质破坏机制选择性降解治疗相关蛋白质的小分子药物。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4007":"制药","BK4539":"次新股","LENZ":"Therapeutics","BK4139":"生物科技","GLUE":"Monte Rosa Therapeutics"},"translate_title":"Monte Rosa Therapeutics, Inc. shares tumbled 5.29% during intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GLUE":1,"LENZ":1},"content_text":"北京时间2025年05月22日01时21分，Monte Rosa Therapeutics, Inc.（GLUE.us）股票出现异动，股价快速下挫5.29%。截至发稿，该股报3.94美元/股，成交量25.6369万股，换手率0.42%，振幅4.09%。最近的财报数据显示，该股实现营业收入84.93百万美元，净利润46.89百万美元，每股收益0.57美元，毛利82.88百万美元，市盈率33.08倍。机构评级方面，在所有9家参与评级的机构中，89%的券商给予买入建议，11%的券商给予持有建议，无券商给予卖出建议。Monte Rosa Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.06%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 (To Pur Com)、Apollomics Inc C/Wts 01/04/2028 (To Pur Ord)、Psyence Biomedical Ltd C/Wts 25/01/2029(To Pur Com)涨幅较大，Polyrizon Ltd.、Aptevo Therapeutics Inc.、Nucana Plc较为活跃，换手率分别为9599.29%、1429.83%、1075.76%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 (To Pur Com)、Psyence Biomedical Ltd C/Wts 25/01/2029(To Pur Com)、Aptevo Therapeutics Inc.，振幅分别为659.17%、232.26%、131.27%。Monte Rosa Therapeutics, Inc.公司简介：Monte Rosa Therapeutics Inc 是一家生物技术公司，专门开发分子胶降解剂（MGDs），这是一类利用人体天然蛋白质破坏机制选择性降解治疗相关蛋白质的小分子药物。利用 QuEEN 平台，该公司采用人工智能和专有实验工具来识别 MGD 降解的目标蛋白质。拥有超过 50,000 个 MGD 分子的多样化文库，他们最先进的候选产品——MRT-2359，针对可用于 MYC 驱动的肿瘤的，翻译终止因子蛋白 GSPT1。 该公司的重点在于推进其 MGD 产品，旨在为各种疾病提供新颖的治疗方式。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2537958136","isCrawlerRequest":true}

Monte Rosa Therapeutics, Inc.盘中异动 股价大跌5.29%

精彩评论

Monte Rosa Therapeutics, Inc.盘中异动股价大跌5.29%